Thursday, 22 October 2015

mHealth Generation: An era of bringing healthcare to smartphones

mHealth Generation: An era of bringing healthcare to smartphones and ensuring its successful implementation

-          By Padma Shri Awardee Dr Marthanda Pillai, Honorary National President Indian Medical Association and Dr KK Aggarwal, President HCFI & Honorary Secretary General Indian Medical Association

Delegates from almost 60 national medical associations attended the annual General Assembly of the WMA in Moscow, which was held from 14th to 17th  October.  And all of them insisted on the importance of a few improvisations required for successfully leveraging Mobile Healthcare in the country. Not only it will help developing countries, but it will also help in wholistically improving the healthcare model in developed countries as well.

In today’s time, technology and the world both are developing at the highest pace. And the best example of this is the evolving movement of smartphones. Smartphones have made our lives easier by making things easily accessible and simultaneously saving our time. Not only, they have successfully transformed our lives but have also brought necessities much closer. For instance, how well the concept of mHealth (Mobile Health) has resonated with people from all across the globe.

According to WMA, “Mobile health (mHealth) is used to define the utilization of state-of-the-art technology in medical care. More specifically, it has been described as medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs), and other devices intended to be used in connection with mobile devices. It includes voice and short messaging services (SMS), applications (apps), and the use of the global positioning system (GPS) for the successful deliverance of medical services.” 

mHealth is a broad concept and encompasses services like measurement or manual input of medical, physiological, lifestyle, activity and environmental data in order to fulfill their primary purpose. All this will result in data generation, which can be used for research into effective healthcare delivery and disease prevention. However, this data can also be misused if the required security checks are missed.
Although, there are a plethora of policies that safeguard the whole idea of mobile health and ensure security as certain levels including the collection, storage, protection and processing of data of mHealth users, especially health data. The Government should focus on educating people about how their personal data is collected, stored, protected and processed. Prior to any confirmation, consent must be obtained prior from the users to any disclosure of data to third parties, e.g. researchers, governments or insurance companies. These steps will help in avoiding any discrepancies, which may hinder the successful implementation of Mobile Health technology.
Mobile Health will be huge hit if monitoring and evaluation are done in accordance to stated rules and regulations. This will avoid any possibilities in breach of information and as well as the user’s trust. Additionally, timely monitoring and evaluation will help in avoiding any misuse of this technology and will also make it easier to measure the performance records with predetermined standards.
The Mobile Health should be made a universal concept and the access shouldn’t be denied based on factors like caste, financial status or lack of technical expertise. And wherever possible, social or healthcare services should facilitate access to mHealth technologies as part of basic benefit packages, while taking all the required precautions to guarantee data security and privacy.
Why is mHealth important?

·         Mobile technologies, being easily accessible can provide individual level support to health care consumers
·         It will promote healthcare, as apps that can track daily calorie intake, calories burn, exercises done and much more. All this will educate people on when they should stop
·         It will help people to get a top physician’s advice in emergency situations like sudden pain in case of pregnant women
·         With more and more giant tech players investing in a developing country like India, the smartphone network is likely to expand. Mobile Health will make it easier for people to access healthcare services from anywhere at anytime. Although the usage and availability may vary in some places.

Nowadays, multinational tech giants are making efforts towards manufacturing low-cost smartphones keeping purchasing power of the Indian population in mind. More and more people are adapting the smartphone craze, as they are getting all the hi-tech services and features in minimum amount. Additionally, these numbers are going to increase in the near future as India continues to develop and emerge as a global power.
The idea of mHealth has the remarkable potential to supplement the healthcare delivery model in a country, which has a population of 1.27 billion people. This will help in improving various fronts like patient self-management, establishing base for electronic interactions between patients and physicians and reducing the cost of the healthcare services.
The future of mHealth depends on new coordinated and well researched the plan of action will be.  The decisions that have been taken before for the implementation of Mobile healthcare system has been way too experimental in nature and doesn’t have any guarantee of data security and privacy. The technological arrangement should be such that it enables in achieving the ultimate desired results. An extensive plan and comprehensive approach is what is currently required for the successful integration of this technology into the regular healthcare infrastructure.


WMA guidelines:

·         Although, the WMA recognizes the advantages of mHealth, the patient should always opt for face-to-face interaction and treatment whenever possible

·         The need to eliminate deficiencies in the provision of care and to improve the quality of healthcare should be the two main objectives behind mHealth

·         Physicians and patients both should be aware about the potentials risks of using mHealth and should follow the guidelines strictly

·         A physician and a patient should clearly understand the difference between the use of mHealth for lifestyle purposes and the ones that require medical supervision and observation

·         The information provided must be clear, reliable and non-technical, and therefore comprehensible to lay people

·         Concerted work must go into improving the interoperability, reliability, functionality and safety of mHealth technologies, e.g. through the development of standards and certification schemes

·         Comprehensive and independent evaluations must be carried out by competent authorities with appropriate medical expertise on a regular basis in order to assess the functionality, limitations, data integrity, security and privacy of mHealth technologies

·         Suitable reimbursement models must be set up in consultation with national medical associations and healthcare providers to ensure that physicians receive appropriate reimbursement for their involvement in mHealth activities

·         A clear legal framework must be drawn up to address the question of identifying potential liability arising from the use of mHealth technologies

·         Physicians who use mHealth technologies to deliver healthcare services should heed the ethical guidelines set out in the WMA Statement on Guiding Principles for the Use of Telehealth for the Provision of Health Care




Wednesday, 16 September 2015

Dengue 4 is less fatal: IMA

Dengue 4 is less fatal: IMA
It’s not an epidemic yet: IMA

IMA today released dengue guidelines and said not to panic. The present serotype is less fatal than the one whish was in 2013.
Addressing a press meet here Dr K K Aggarwal, Padma Shri Awardee and Honorary secretary General IMA said that only suspected severe dengue cases needs medical attention and admission. Most can be managed as OPD care. IMA said NO to platelet transfusion unless patient has active bleed and count less than 10,000.

Platelets counts by machine readings are bot reliable and can have an error of upto 40,000.
The reliable test is haematocrit and not platelet count. Most cases can be manages without testing by only measuring difference between upper and lower blood pressure. The pulse pressure should be kept over 40 mm Hg.
IMA also appealed to the public not to panic and do not force doctors to admit you unless it is important.
“ do bot fill beds with patients not requiring admission. Make beds available for sever dengue cases” added Dr Aggarwal.

Co-addressing the press Dr V K Monga and Dr R N Tandon from IMA said that most dengue patients can be managed with oral fluids.

New strain of dengue
·         Dengue normally is Den1, Den2, Den 3 and Den4 serotypes.
·         1 and 3 serotypes are less dangerous as compared to 2 and 4 serotypes.
·         This year its 2 and 4 serotypes which are prevalent.
·         As per AIIMS the type 4 strain of the disease has emerged as the dominant type for the first time in the capital, along with dengue type 2
·         Symptoms of type 4 dengue include fever with shock and a drop in platelets, type 2 causes a severe drop in platelets, haemorrhagic fever, organ failure and dengue shock syndrome.
·         Every strain carries the risks of hemorrhagic fever, but type 4 is less virulent than type 2. Risk of severe dengue is highest with dengue-2 viruses.
·         Barring stray cases in 2003, the type 4 strain of the virus has never been isolated in Delhi
·         Doctors were expecting the strain to change this year, given the large number of cases. Doctors were not expecting type 4 because it has never been actively circulating in Delhi.
·         When the dominant strain remains the same for a long period, a significant population develops immunity to it, and fewer patients are diagnosed with the virus. However the type 4 strain had never even shown a significant presence. A new serotype will always end up with an epidemic like situations
·         Infection with one of the four serotypes of dengue virus (primary infection) provides lifelong immunity to infection with a virus of the same serotype. However, immunity to the other dengue serotypes is transient, and individuals can subsequently be infected with another dengue serotype (secondary infection). Subsequent infection with a second type increases the likelihood of serious illness.
·         The risk for severe dengue appears to decline with age, especially after age 11 years.
·         AIIMS lab is also suspecting a new serotype this year in addition. Is it Den 5 ?.  Researchers screening dengue viral samples found a virus collected during an outbreak in Malaysia's Sarawak state in 2007 that they suspected was different from the four original serotypes. They sequenced the virus and found that it is phylogenetically distinct from the other four types. Experiments found that monkey antibodies produced against the new type differ significantly from those resulting from the previously known dengue viruses.  So far, dengue 5 has been linked to only one outbreak in humans. 
·         In 1996, when an outbreak of the disease was reported in Delhi with over 10,000 cases, the relatively severe type 2 strain of the virus was identified as the most common one.
·         In 2003, when a sharp rise in dengue cases was again reported, type 3, a mild strain, emerged as the most common type.
·         In 2013, with over 5,500 cases, type 2 returned as the common strain in the capital.

Most dengue patients are not serious
·         Dengue is both preventable and manageable
·         The risk of complications is in less than one per cent of dengue cases and, if warning signals are known to the public, all deaths from dengue can be avoided.
·         A platelet transfusion is not needed unless patient has active bleeding (other than petechiae ) and platelet counts are less than 10,000.
·         Unnecessary platelet transfusion can cause more harm than good.
·          Classic dengue fever is an acute febrile illness accompanied by headache, retro orbital pain, and marked muscle and joint pains. Symptoms typically develop between four and seven days after the bite of an infected mosquito. The incubation period may range from three to 14 days. Fever typically lasts for five to seven days. The febrile period may also be followed by a period of marked fatigue that can last for days to weeks, especially in adults. Joint pain, body aches, and rash are more common in females.
·          Most complications of dengue occur after the fever is over. The two days after the last episode of the fever are crucial and during this period, a patient should be encouraged to take plenty of oral fluids mixed with salt and sugar.
·          The main complication is leakage of capillaries and collection of blood outside the blood channels leading to intravascular dehydration. Giving fluids orally or by intravenous routes, if given at a proper time, can save fatal complications
Only these needs admission
"Warning signs" – World Health Organization (WHO) guidelines recommend attention to clinical warning signs for severe dengue
Severe abdominal pain or tenderness
Persistent vomiting, lethargy or restlessness
Abrupt change from fever to hypothermia
Bleeding, pallor
Cold /clammy extremities
Liver enlargement on physical exam
Abnormal mental status

Severe dengue
Early recognition
·         Dramatic plasma leakage often develop suddenly; therefore, substantial attention has been placed on early identification of patients at higher risk for shock and other complications.
·          The period of maximum risk for shock is between the third and seventh day of illness. This tends to coincide with resolution of fever. Plasma leakage generally first becomes evident between 24 hours before and 24 hours after defervescence.
·          An elevation of the hematocrit is an indication that plasma leakage has already occurred and that fluid repletion is urgently required.
·          Low platelet count usually precedes overt plasma leakage.
·          Mild elevations in serum SGOT and SGPT levels are common. Bit in severe dengue the levels are very high with SGOT > SGPT levels
·         A normal SGOT levels is a strong negative predictor of severe dengue even in the first three days of illness
·          NS 1 of >600 ng/mL suggests severe dengue
·         Coexisting medical conditions, such as pregnancy, infancy, old age, obesity, diabetes mellitus, renal failure, and chronic hemolytic disease may increase the risk of severe dengue and/or complicate management. Referral for hospitalization is recommended for such patients, regardless of other findings
·         Additionally, hospitalization should be considered for patients who may have difficulties with outpatient follow-up or with timely self-referral should complications develop (eg, patients who live alone or who live far from a healthcare facility without a reliable means of transport).
·          Patients with suspected dengue who do not have any of the above indicators probably can be safely managed as outpatients, as long as close clinical observation is assured. Daily outpatient visits may be needed to permit serial assessment of blood pressure, hematocrit, and platelet count.
Government may clarify: is it an epidemic
1.       Recent government circulars say: Postpone routine surgeries to accommodate dengue patients/ Postpone routine admissions/ Make provision of extra beds/ Do not refuse any patient who needs admission
2.      These all are done when an epidemic is announced
3.      Ina n epidemic all cases are presumed to be dengue, no confirmatory testing are done, a triage announcement is done, clear cut directions are announce regarding which patients  are to be admitted and which patients re not to be admitted’

Management of significant bleeding
—    Gastrointestinal bleeding, epistaxis, or menorrhagia in patients with severe dengue (and occasionally in patients with dengue fever) can be severe enough to require blood transfusion.
—    Blood replacement should be performed with 5 mL/kg of packed red blood cells (or 10 mL/kg whole blood).
—    Platelet transfusions have not been shown to be effective at preventing or controlling hemorrhage but may be warranted in patients with severe thrombocytopenia (<10,000/mm3) and active bleeding.
—    Prophylactic platelet transfusions in patients with severe thrombocytopenia but without active bleeding are not recommended

Fluid requirement
1.       20 ml/kg body weight as bolus
2.      10 mL/kg over the next first hour
3.      7 mL/kg/hour for next two hours
4.      5 mL/kg/hour for next four hours
5.       3 mL/kg/hour for next 8 hours
 Assessment
Must pass urine every three hours
Duration of extra fluids
The fluids that are lost into potential spaces (eg, pleura, peritoneum) during the period of plasma leakage are rapidly reabsorbed.
Intravenous fluid supplementation should be discontinued once patients have passed the period of plasma leakage. Usually no more than 48 hours of intravenous fluid therapy are required. Excessive fluid administration after this point can precipitate hypervolemia and pulmonary edema

When to discharge
—    In the absence of complications from prolonged hypotension or from medical interventions, most patients with severe dengue recover within a few days of admission
—    No fever for at least 24 hours
—    Two days have passed after an episode of shock
—    Patient is clinically well
—    Normal  normal appetite, urine output, and hematocrit.
No aspirin

Patients with dengue should be cautioned to maintain their fluid intake to avoid dehydration and to take paracetamol as needed for fevers and myalgias. Aspirin or nonsteroidal antiinflammatory agents should generally be avoided. 

Sunday, 2 August 2015

White Paper on Dr. Ketan Desai (Part-II)

White Paper on Dr. Ketan Desai (Part-II)

This has reference to the stories published by Reuters regarding Dr. Ketan Desai who was unanimously elected as President of the World Medical Association (WMA) in October, 2009.

WMA has 111 countries as its members.  India is also a member of the WMA for well over four decades.  India also has one Council Member (which is against the membership of 50,000 Indian doctors), whereby 50,000 IMA members are also the members of WMA represented by a Council Member of thereat.

In October 2009 during WMA Meeting held at New Delhi, Dr. Ketan Desai was unanimously elected as the President-Elect, WMA. Accordingly, Dr. Desai was to take over as the office of the President of WMA in October 2010 in Vancouver, Canada.

On April 22, 2010 when Dr Ketan Desai was President, MCI search was conducted by CBI at his offices at MCI and his house at Ahmedabad and he was taken into custody on the allegation of favouring one private medical college inspite of deficiencies in lieu of money. 

In terms of the Seizure Memo of CBI of Delhi dt. 22/4/2010, no cash was recovered and vide Seizure Memo of CBI at Ahmedabad dt. 22/4/2010, a cash of Rs.53,400/- was recovered.  The same was not seized and handed over to Dr. Alka Desai, his wife  (Annex I – See page No. 5 and Annex IA  -PDF attached).

The media on the next day vociferously highlighted that Dr. Ketan Desai was caught red handed taking a bribe of Rs. 2 Crores for giving wrongful permission to Gian Sagar Medical College, which was patently false, concocted  and mischievous  as both Seizure Memos do not corroborate with the same.

IMA Enquiry committee went through the charge-sheet of the CBI in Gian Sagar Medical College original case and found that charges against  Dr. Desai was recommending permission by MCI to the said medical college while he was holding the position of President MCI, for the  4th batch inspite of deficiency being noted. As per CBI charge sheet only deficiency in the college was of auditorium and yet the permission was recommended.

IMA went through the inspection report of MCI dt. 22/3/10 (Annex 2 - PDF attached )  and noted that MCI inspection report has also mentioned the “the auditorium is under construction".

IMA went through the MCI Laws and requirements and noted that for the permission to admit 4th batch in a  medical college ‘auditorium’ is not required as against the prescribed statutory requirements but is required for the  admission of 5th batch in terms of the Governing Regulations of the Council on Minimum Standard Requirements (Annex 3 -PDF attached ).

The next day i.e 23/4/2010, the CBI also inspected the College and found that except  auditorium there was no other deficiency  in the college, which was consistent with the findings incorporated in the report submitted by the inspectors of MCI and considered by the Medical Council of India.

On 25th April the then Union Health Minister Sh Gulam Nabi Azad ordered to constitute a high level committee to verify the correctness of the report and recommendation of MCI (annexure pdf )

Accordingly a three member committee was constituted on 26th April ( annexure pdf) led by Mr. Keshav DesiRaju.

On 29th April, Ministry of Health, a team led by Mr. Keshav DesiRaju the then Additional secretary, Dr. Arun Aggarwal (ADGHS) and Dr. Rani Kumar Dean of AIIMS New Delhi also inspected the said medical college and submitted their report. In this report too it has been stated that ‘auditorium was not available’. However inspite of the same the Committee observed and concluded that " the recommendations made by the Executive Committee of the MCI at its meeting on 5.4.2010 to grant permission for admission of 100 students in the year 2010-11 for the fourth batch of MBBS students at the Gian Sagar Medical College & Hospital, Patiala was justified on the basis of the report of the Council Inspectors and the compliance report of made by the Principal. The observations made in the first report have been rectified. Further, the existing facilities and faculty at Gian Sagar Medical College and Hospital appear more than adequate to conduct undergraduate medical teaching.

The said report ( dated 3rd May) was forwarded by the Secretary, Ministry of Health, Government of India Ms Sujata Rao to the Director, CBI on 11th May 2010. (annexure pdf)

Thereafter one more inspection was conducted by the Board of Governors appointed by the Central Government. Report dt. 16th/17th June 2010 of the team of inspectors appointed by the Board of Governors also mentioned that no auditorium was available ( Annex 5 - PDF attached ). Accordingly, Board of Governors also accorded permission on 12.7.2010 (Annex 6 - PDF attached ).

IMA internal enquiry failed to decipher why media carried the news that Dr. Desai was caught red handed taking bribe of Rs.2 Crores as against the material fact that the Seizure Memo showed that no cash was recovered from him.  Further, the main allegation against him was that the MCI had recommended permission for the said college while he was the President inspite of non availability of Auditorium. However, as per the MCI regulation it is not required and later CBI, Ministry of Health & Board of Governors respectively conducted the inspections and submitted their reports and the said medical college was finally accorded permission to admit 4th batch on 12/7/10 inspite of the non availability of Auditorium, which was noted by MCI in its earlier inspection.

The projected error on the said count was justifiable exclusively on the ground in case the Central Government, Board of Governors, MCI would have denied the permission to this college due to the non availability of auditorium.  The very fact, MCI Board of Governors appointed by central Government gave permission to admit 4th batch to said medical college, clearly brought to fore that  the allegations were bereft of any merit, whatsoever.

Lucknow Case:

A)    MCI Inspection was done on 20th /21st February, 2009. Dr. Desai was not the President of MCI then. Dr. Suresh Shah, MCI Inspector, in his statement under section 164 stated that Dr. Ketan Desai as the President MCI instructed him to be strict in the inspection.

It is pertinent to note that Dr. Desai was not President at the given time.

B.) The chargesheet of CBI Lucknow case mentions irregularities about 12 Faculty doctors.

1)      In cases pertaining to 4 doctors’ cases, Ration cards were submitted by them as proof of residence, which were found to be not genuine by CBI.

However, they have been faculty at the said college, much before that and have been consistently accepted as the teaching faculty by MCI.  Dr. Desai was not the President MCI during the concerned period and the affairs of the Medical Council of India were monitored by an Ad-hoc Committee appointed by the Hon'ble Supreme Court.

2)      In another 4 cases, during inspection in Feb. 2009, 4 doctors were shown to be staying at doctor’s quarters in the campus, as per the declaration form by them and endorsed by the Dean of the college. When CBI inspected in Aug. 2010 (after 18 months), these 4 doctors were found not staying in the doctor’s quarter on that day.

c)      In the rest 4 cases, doctors did not fill form-16 in their income tax returns.
(Kindly note in all these 12 cases, where is any role attributable to the President of the Medical Council of India)

Allegation of the CBI was that in case the inspection team would have picked up these shortcomings of 12 Doctors, the College would not have been given permission to admit the fresh batch of students.

Follow up:

Lucknow High Court on 16/02/2015 quashed corruption charges against Dr. Ketan Desai under POCA in its entirety. As regards, his involvement in cheating and conspiracy under IPC 420 and 120-B , the Court is yet to decide about framing the charges. Till date no charges have been framed by the competent court. 

IMA has in its possession the affidavit filed by the CBI in Lucknow High court in March 2014  (Annex– 7 PDF attached ). The relevant para is reproduced as under:  

(i) Whether there is any evidence of meeting of mind or criminal conspiracy against the accused Dr. Ketan Desai with other co-accused person?

Reply of CBI: There is no direct evidence of meeting of mind or criminal conspiracy of Dr Ketan Desai with other co-accused persons. The circumstantial evidence in this regard has been detailed in the counter affidavit filed by CBI on 04.04.2013.

(ii) Whether there is any evidence of quid-pro-quo against the accused Dr Ketan Desai?

Reply of CBI: There is no evidence of quid-pro-quo against the revisionist Dr Ketan Desai in the instant case.

(iii)Whether there is any evidence against the accused Dr Ketan Desai in respect of demand/acceptance/obtainment of any valuable thing/pecuniary advantage?

Reply of CBI: There is no evidence against accused Dr Ketan Desai in respect of demand/acceptance/ obtainment of any valuable thing/pecuniary advantage for himself. As regards the pecuniary advantage caused to the said private medical college mention has been made in the counter affidavit filed by CBI on 04.04.2013.

After going through these 3 replies from CBI, IMA internal enquiry  Committee  is of the considered opinion that there is not even an iota of evidence against Dr. Ketan Desai under IPC 420 & 120B.However, the Court is yet to decide the case on the merit.

Disproportionate Assets (DA) Case closure

The case of D.A was registered by the CBI in May 2010 against Dr. Ketan Desai and his family members for the period 1/1/97 to 22/4/2010.

After detailed investigation by the CBI, over a period of 2 years, CBI in May 2012 filed a closure report before the Competent Court stating that all accounts/assets in possession of Dr. Desai and his family members are genuine and possession known to legal sources of his and the income of his family members.  The Competent Court after due scrutiny accepted the closure report submitted by CBI.  As a consequence thereto an appropriate order of removal of any impediment in relation to the assets and bank accounts was also made.

IMA internal enquiry further went into the details of Dr. Desai’s Income Tax Returns. His income scrutiny case decided on 27/4/2001 ( Annex-8 - PDF attached ) showed  that from 1/4/90 to 18/7/2000 his undisclosed income was 'NIL'.

The DA case revealed that there was no undisclosed income from 1/1/96 to 22/4/10.

Corroborating the income tax assessment order & DA Report of CBI, it is loud and clear that from 1/4/90 to 22/4/10 for over two decades he and his family member had no undisclosed income.
Both the Income Tax Department and CBI could not find any source of undisclosed/unknown income during the said period spread well over two decades.

The case for disproportionate assets, invariably, begins with the allegation that the assets held are disproportionate to known legal sources of income and therefore, it has to be assumed / accepted that possession of such assets, which are beyond the known legal sources must be from illegal sources say bribe etc. If upon through investigation, the investigating authority  concludes that the assets, which are held by the person under investigation, are proportionate to the known sources of his income then in that case, all the allegations of illegal sources of income such as bribe etc. automatically stand to be rejected.  No such allegation would then survive in any form.  As such, it can be convincingly, concludingly and safely stated that Closure of DA case means that all financial corruptions charges against a person are found to be false and baseless.

Correspondence with WMA:

In 2013, on the basis of these documents, IMA approached WMA to reinstate the Presidentship of Dr. Desai which was held in abeyance because of cases pending against him.

WMA asked for the official correspondence regarding pending case against Dr. Ketan Desai.

Accordingly, the IMA informed the WMA that they have corresponded with the CBI to get the list of all pending cases.

IMA received a letter dt. 22/4/14 (Annex-9 - PDF attached) from the CBI which clearly mentioned that the DA case against him has been closed, as no cash was recovered from Dr. Ketan Desai during search.  In Calcutta, Chennai and Hyderabad cases, no evidence was found against Dr. Desai and he was given clean chit. In Lucknow case, charges are yet to be framed and in  Delhi case, the proceedings have been stayed by the Hon'ble Supreme Court.
The copy of CBI letter to the above effect was submitted to the WMA.

WMA upon going through the documents so submitted including the Court orders and the correspondence, decided that Dr. Ketan Desai will legitimately take over as the President of the WMA in October 2016.

Nowhere IMA withheld any information of any type or made any attempt whatsoever to misguide the WMA.  The crux of the documentation is the CBI letter and the court orders from time to time, which are in possession of WMA.

IMA in April 2015, brought out a White Paper (part 1)  on Dr. Ketan Desai and placed it on its Website ( http://www.ima-india.org/ima/news.php?nid=7) for the information of all concerned by making it a public document.

Is Dr. Ketan Desai a valid Member of  MCI:

Now and then, media reports that registration held by Dr. Ketan Desai has been suspended by the MCI.  As per IMC Act, one needs to be  registered through the State Medical Council and in the case of Dr. Ketan Desai it is  Gujarat State Medical Council.  His license to practice modern medicine in terms of his registration with the Gujarat State Medical Council was never suspended. However, MCI after his arrest, suspended his license which was later revoked in January 2015.  As per statutory regulations MCI is supposed to decide the matter/complain within six months, but in his case MCI did not complete the said enquiry till the elected body took over (almost 3 years).  During this period, his license to practice of Gujarat Medical Council was never questioned by the MCI.  He remained enrolled continuously without any break  on the State medical register  of Gujarat State Medical Council.  As on today, his name appears in the IMR, maintained by the Medical Council of India. [http://www.mciindia.org/InformationDesk/IndianMedicalRegister.
aspx]
64
1981
G-11666
Gujarat Medical Council, Desai Ketan Dhiraj Lal

Desai Ketan Dhiraj Lal

Correspondence of Reuters:

Apart from verbal interviews, Reuter reporters communicated with the Hony. Secretary General of IMA as well as Dr Ketan Desai.  The answers given by Dr. Ketan Desai & IMA are annexed herewith (Annex 10, 11, 12 & 13  - PDF Attached).

In no way, IMA has withheld any information.  Whatever IMA has corresponded with the WMA, was based on the reports of the closure of D.A Case and letter received from CBI and the court orders from time to time.

IMA Stand:

1.   Dr. Ketan Desai is IMA’s nominee for the post of President, WMA.
2.   He is not there in an individual capacity.
3.   IMA’s internal enquiry has clearly shown that he is a victim of circumstances and possible conspiracy at the hands of vested interest plagued and pained at his tough principled policy stands.
4.   IMA is not convinced that he has been indulging in any corrupt practices. IMA had and continues to hold impeccable faith in the judicial proceedings and shall abide by the pronouncements / orders of the Hon'ble Courts.
5.   IMA is also aware of the Indian Laws that unless convicted one is held to be innocent. Simply an pending FIR does not disqualify anyone from assuming any higher position as the cases may linger on endlessly plagued by delays and latches in India.  For e.g., even upon more than four years of time having lapsed in the Lucknow case whether to frame charges against Dr. Desai or not till date has remained and decided. As such, he has to be taken as innocent until and unless he is proved to be guilty and convicted for the same.
6.   Imagine, Dr Desai is asked to resign and by next October 2016, before he is scheduled to take over, he is cleared of both the court cases.
7.   IMA with all strength at its disposal stands by its decision that Dr. Ketan Desai is a validly nominated and duly elected as the President, WMA in 2016.

Media Reacts